• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sphingosine kinase-1: a potential mediator of renal fibrosis.

作者信息

Long David A, Price Karen L

机构信息

University College London, Institute of Child Health, UK.

出版信息

Kidney Int. 2009 Oct;76(8):815-7. doi: 10.1038/ki.2009.310.

DOI:10.1038/ki.2009.310
PMID:19789541
Abstract

Renal fibrosis contributes to glomerulosclerosis and tubulointerstitial damage in chronic kidney disease. A well-established pathway implicated in the progression of fibrosis is the induction of connective tissue growth factor by transforming growth factor-beta, resulting in the accumulation of extracellular matrix proteins. Ren and colleagues demonstrate that sphingosine kinase-1 is involved in the regulation of this pathway in the glomerulus. This raises the possibility of targeting sphingosine kinase-1 to prevent fibrosis in chronic kidney disease patients.

摘要

相似文献

1
Sphingosine kinase-1: a potential mediator of renal fibrosis.
Kidney Int. 2009 Oct;76(8):815-7. doi: 10.1038/ki.2009.310.
2
Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression.转化生长因子-β2上调鞘氨醇激酶-1的活性,而鞘氨醇激酶-1活性反过来又通过抑制结缔组织生长因子(CTGF)的表达来减弱对转化生长因子-β2的纤维化反应。
Kidney Int. 2009 Oct;76(8):857-67. doi: 10.1038/ki.2009.297. Epub 2009 Aug 5.
3
Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.靶向鞘氨醇激酶/鞘氨醇 1-磷酸途径治疗慢性炎症性肾病。
Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):44-9. doi: 10.1111/bcpt.12103. Epub 2013 Jul 15.
4
Sphingosine Kinase-1/sphingosine 1-phosphate pathway in diabetic nephropathy.糖尿病肾病中的鞘氨醇激酶-1/1-磷酸鞘氨醇途径
Chin Med J (Engl). 2014;127(16):3004-10.
5
Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.肝生素 Cn 通过鞘氨醇激酶 1 和鞘氨醇 1-磷酸受体减少乙醇诱导的肝毒性。
J Pathol. 2013 Aug;230(4):365-76. doi: 10.1002/path.4194.
6
When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.当鞘氨醇激酶1/1-磷酸鞘氨醇途径与缺氧信号传导相遇时:癌症治疗的新靶点。
Cancer Res. 2009 May 1;69(9):3723-6. doi: 10.1158/0008-5472.CAN-09-0389. Epub 2009 Apr 21.
7
Cellular signalling by sphingosine kinase and sphingosine 1-phosphate.鞘氨醇激酶与1-磷酸鞘氨醇介导的细胞信号传导
IUBMB Life. 2006 Aug;58(8):467-72. doi: 10.1080/15216540600871126.
8
New perspectives on the role of sphingosine 1-phosphate in cancer.1-磷酸鞘氨醇在癌症中作用的新视角
Handb Exp Pharmacol. 2013(216):55-71. doi: 10.1007/978-3-7091-1511-4_3.
9
Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway.姜黄素通过抑制 SphK1-S1P 信号通路的激活来改善糖尿病肾病。
Mol Cell Endocrinol. 2013 Jan 30;365(2):231-40. doi: 10.1016/j.mce.2012.10.024. Epub 2012 Nov 2.
10
Discovery of novel sphingosine kinase 1 inhibitors.新型鞘氨醇激酶 1 抑制剂的发现。
Bioorg Med Chem Lett. 2009 Nov 1;19(21):6119-21. doi: 10.1016/j.bmcl.2009.09.022. Epub 2009 Sep 10.

引用本文的文献

1
Gadolinium-based contrast media exposure and the possible risk of subclinical kidney damage: a pilot study.基于钆的造影剂暴露与亚临床肾脏损伤的可能风险:一项初步研究。
Int Urol Nephrol. 2021 Sep;53(9):1883-1889. doi: 10.1007/s11255-020-02779-2. Epub 2021 Jan 13.
2
Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors.2-(羟甲基)吡咯烷骨架的亲脂尾修饰揭示了双重鞘氨醇激酶 1 和 2 抑制剂。
Bioorg Med Chem. 2021 Jan 15;30:115941. doi: 10.1016/j.bmc.2020.115941. Epub 2020 Dec 13.
3
Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2.
鞘氨醇激酶 1 通过防止 miR-19b-3p 介导的 CCR2 抑制来促进肝纤维化。
Hepatology. 2018 Sep;68(3):1070-1086. doi: 10.1002/hep.29885. Epub 2018 Apr 27.
4
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.哺乳动物鞘氨醇激酶(SphK)同工酶及异构体表达:鞘氨醇激酶作为肿瘤靶点面临的挑战
Oncotarget. 2017 May 30;8(22):36898-36929. doi: 10.18632/oncotarget.16370.
5
Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles.含恶二唑的脒基鞘氨醇激酶1抑制剂的结构要求和对接分析
ACS Med Chem Lett. 2016 Mar 1;7(5):487-92. doi: 10.1021/acsmedchemlett.6b00002. eCollection 2016 May 12.
6
Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells.噻唑烷二酮依赖性激活鞘氨醇激酶 1 可在肾小球系膜细胞中产生抗纤维化作用。
Br J Pharmacol. 2012 Jun;166(3):1018-32. doi: 10.1111/j.1476-5381.2012.01824.x.